Cardiex Limited (CDX) is a global health technology company that focuses on hypertension, cardiovascular disease, and other vascular health disorders.
SOI: 294,174,568 Market Cap: $20,592,220
Initial production units of the Conneqt Pulse are scheduled to arrive the first week of July. These units are being distributed to their initial “pilot” partners, key opinion leaders (KOL’s), and members of their clinician network. The first full (3,000 unit) production run and deliveries to the US are scheduled for Q1 FY25. As a bonus CardieX is on track to exceed $12m for FY24 compared to $6.01m for FY23.
